These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 39043640)

  • 21. Body mass index and all-cause mortality in HUNT and UK biobank studies: revised non-linear Mendelian randomisation analyses.
    Burgess S; Sun YQ; Zhou A; Buck C; Mason AM; Mai XM
    BMJ Open; 2024 May; 14(5):e081399. PubMed ID: 38749693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on Disease-Specific Biomarkers in Transthyretin Cardiac Amyloidosis.
    Hood CJ; Hendren NS; Pedretti R; Roth LR; Saelices L; Grodin JL
    Curr Heart Fail Rep; 2022 Oct; 19(5):356-363. PubMed ID: 35930129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic Screening for Pathogenic Transthyretin Variants Finds Evidence of Underdiagnosed Amyloid Cardiomyopathy From Health Records.
    Carry BJ; Young K; Fielden S; Kelly MA; Sturm AC; Avila JD; Martin CL; Kirchner HL; Fornwalt BK; Haggerty CM;
    JACC CardioOncol; 2021 Oct; 3(4):550-561. PubMed ID: 34746851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and Outcomes of p.Val142Ile
    Chandrashekar P; Alhuneafat L; Mannello M; Al-Rashdan L; Kim MM; Dungu J; Alexander K; Masri A
    Circ Genom Precis Med; 2021 Oct; 14(5):e003356. PubMed ID: 34461737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac amyloidosis: a review and report of a new transthyretin (prealbumin) variant.
    Hesse A; Altland K; Linke RP; Almeida MR; Saraiva MJ; Steinmetz A; Maisch B
    Br Heart J; 1993 Aug; 70(2):111-5. PubMed ID: 8038017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac Amyloidosis Due to Transthyretin Protein: A Review.
    Ruberg FL; Maurer MS
    JAMA; 2024 Mar; 331(9):778-791. PubMed ID: 38441582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-Cardiac Amyloidosis Findings Are Not Increased in African American Carriers of
    Kaniper S; Lynch D; Owens SM; Ibric L; Vabishchevich Y; Nyantakyi N; Chun F; Sam L; Fabrizio C; Hamad E; Gerhard GS
    J Pers Med; 2024 Feb; 14(3):. PubMed ID: 38541013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The "Wagshurst study": p.Val40Ile transthyretin gene variant causes late-onset cardiomyopathy.
    Bauer R; Dikow N; Brauer A; Kreuter M; Buss S; Evers C; Röcken C; Schnabel PA; Hinderhofer K; Ehlermann P; Katus HA; Kristen AV
    Amyloid; 2014 Dec; 21(4):267-75. PubMed ID: 25291558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of prediction models for cardiovascular and mortality risk in people with type 2 diabetes: An external validation in 23 685 adults included in the UK Biobank.
    Zhang Y; Jiong OX; Tang S; Tang YC; Wong CT; Ng CS; Quan J
    Diabetes Obes Metab; 2024 May; 26(5):1697-1705. PubMed ID: 38297974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations of decreased serum transthyretin with elevated high-sensitivity CRP, serum copper and decreased hemoglobin in ambulatory elderly women.
    Tsuboi A; Terazawa-Watanabe M; Kazumi T; Fukuo K
    Asia Pac J Clin Nutr; 2015; 24(1):83-9. PubMed ID: 25740746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-Reactive Protein and Heart Failure in Patients With Established Cardiovascular Disease: Evidence From UK Biobank.
    Morze J; Rynkiewicz A
    J Am Coll Cardiol; 2023 Nov; 82(20):e191-e192. PubMed ID: 37940236
    [No Abstract]   [Full Text] [Related]  

  • 32. Non-Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis.
    Hirakawa K; Takashio S; Marume K; Yamamoto M; Hanatani S; Yamamoto E; Sakamoto K; Izumiya Y; Kaikita K; Oda S; Utsunomiya D; Shiraishi S; Ueda M; Yamashita T; Yamashita Y; Ando Y; Tsujita K
    ESC Heart Fail; 2019 Feb; 6(1):122-130. PubMed ID: 30284755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reply: C-Reactive Protein and Heart Failure in Patients With Established Cardiovascular Disease: Evidence From UK Biobank.
    Burger PM; Visseren FLJ; Dorresteijn JAN
    J Am Coll Cardiol; 2023 Nov; 82(20):e193. PubMed ID: 37940237
    [No Abstract]   [Full Text] [Related]  

  • 34. Modification effect of ideal cardiovascular health metrics on genetic association with incident heart failure in the China Kadoorie Biobank and the UK Biobank.
    Yang R; Lv J; Yu C; Guo Y; Pei P; Huang N; Yang L; Millwood IY; Walters RG; Chen Y; Du H; Tao R; Chen J; Chen Z; Clarke R; Huang T; Li L;
    BMC Med; 2021 Oct; 19(1):259. PubMed ID: 34674714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of Serum Transthyretin as a Prognostic Indicator and Predictor of Outcome in Cardiac Amyloid Disease Associated With Wild-Type Transthyretin.
    Hanson JLS; Arvanitis M; Koch CM; Berk JL; Ruberg FL; Prokaeva T; Connors LH
    Circ Heart Fail; 2018 Feb; 11(2):e004000. PubMed ID: 29449366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation into thiol conjugation of transthyretin in hereditary transthyretin amyloidosis.
    Suhr OB; Ando Y; Ohlsson PI; Olofsson A; Andersson K; Lundgren E; Ando M; Holmgren G
    Eur J Clin Invest; 1998 Aug; 28(8):687-92. PubMed ID: 9767365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of age and amyloidosis on thiol conjugation of transthyretin in hereditary transthyretin amyloidosis.
    Suhr OB; Svendsen IH; Ohlsson PI; Lendoire J; Trigo P; Tashima K; Ranløv PJ; Ando Y
    Amyloid; 1999 Sep; 6(3):187-91. PubMed ID: 10524283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spectrum of transthyretin gene mutations and clinical characteristics of Polish patients with cardiac transthyretin amyloidosis.
    Gawor M; Holcman K; Franaszczyk M; Lipowska M; Michałek P; Teresińska A; Bilińska ZT; Rubiś P; Kostkiewicz M; Szot W; Podolec P; Grzybowski J
    Cardiol J; 2022; 29(6):985-993. PubMed ID: 32789836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low Prevalence of Clinically Apparent Cardiac Amyloidosis Among Carriers of Transthyretin V122I Variant in a Large Electronic Medical Record.
    Agbor-Etang BB; Okafor HE; Farber-Eger EH; Wells QS
    Am J Med; 2021 Feb; 134(2):e98-e100. PubMed ID: 32866461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology.
    Skrahina V; Grittner U; Beetz C; Skripuletz T; Juenemann M; Krämer HH; Hahn K; Rieth A; Schaechinger V; Patten M; Tanislav C; Achenbach S; Assmus B; Knebel F; Gingele S; Skrahin A; Hartkamp J; Förster TM; Roesner S; Pereira C; Rolfs A
    Ann Med; 2021 Dec; 53(1):1787-1796. PubMed ID: 34658264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.